1. Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation. (26th February 2018) Authors: Cedrés, Susana; Felip, Enriqueta; Cruz, Cristina; Martinez de Castro, Ana; Pardo, Nuria; Navarro, Alejandro; Martinez-Marti, Alex; Remon, Jordin; Zeron-Medina, Jorge; Balmaña, Judith; Llop-Guevara, Alba; Miquel, Josep M; Sansano, Irene; Nuciforo, Paolo; Mancuso, Francesco; Serra, Violeta; Vivanco... Journal: Journal of the National Cancer Institute Issue: Volume 110:Number 8(2018) Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial. Issue 4 (April 2022) Authors: Kindler, Hedy L; Novello, Silvia; Bearz, Alessandra; Ceresoli, Giovanni L; Aerts, Joachim G J V; Spicer, James; Taylor, Paul; Nackaerts, Kristiaan; Greystoke, Alastair; Jennens, Ross; Calabrò, Luana; Burgers, Jacobus A; Santoro, Armando; Cedrés, Susana; Serwatowski, Piotr; Ponce, Santiago; Van Me... Journal: Lancet oncology Issue: Volume 23:Issue 4(2022) Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer. Issue 4 (6th January 2021) Authors: Frigola, Joan; Navarro, Alejandro; Carbonell, Caterina; Callejo, Ana; Iranzo, Patricia; Cedrés, Susana; Martinez‐Marti, Alex; Pardo, Nuria; Saoudi‐Gonzalez, Nadia; Martinez, Debora; Jimenez, Jose; Sansano, Irene; Mancuso, Francesco M.; Nuciforo, Paolo; Montuenga, Luis M.; Sánchez‐Cespedes, Montse... Journal: Molecular oncology Issue: Volume 15:Issue 4(2021) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗